诺舒阻抗控制子宫内膜切除术的临床应用现状

摘要
图/表
参考文献
相关文章 (9)

[1]	Fraser I S,Critchley H,Broder M.The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding[J]. Semin Reprod Med, 2011, 29(5): 383-390.
[2]	R J. Ten-year literature review of global endometrial ablation with the NovaSure device [J]. Int J Womens Health, 2014, 6: 269-280.
[3]	宋菁华,李斌,刘桂芝.诺舒(NovaSure) 阻抗控制子宫内膜切除系统治疗异常子宫出血的临床研究[J].中国微创外科杂志,2011,11(12):1125-1127.
[4]	Potti S, Uppal S, Ashwin J, et al. NovaSure as a mechanical endometrial preparation agent in large uteri [J]. JSLS, 2012, 16: 537-541.
[5]	Kalkat R K,Cartmill R S. NovaSure endometrial ablation under local naesthesia in an outpatient setting:an observational study[J]. J Obstet Gynaecol, 2011, 31(2): 152-155.
[6]	Sabbah R, Desaulniers G. Use of the NovaSure impedance controlled endometrial ablation system in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study [J]. J Minim Invasive Gynecol, 2006, 13(5): 467-471.
[7]	葛静,万亚军,肖松舒,等.诺舒治疗尿毒症合并月经过多26例临床分析[J].中外医学研究,2013,11(15):12-13.
[8]	刘青,张华,刘继娟.诺舒阻抗控制子宫内膜切除治疗肝病合并异常子宫出血30例[J].中国微创外科杂志,2014,14(4):304-307.
[9]	Gurtcheff S E, Sharp H T. Complications associated with global endometrial ablation: the utility of the MAUDE database [J].Obstetynecol, 2003, 102(6): 1278-1282.
[10]	Hologic, Inc. NovaSure impedance-controlled endometrial ablation system: instructions for use and controller’s manual [M]. Marlborough, MA: Hologic, Inc, 2010.
[11]	Brown J, Blank K. Minimally invasive endometrial ablation device complications and use outside of the manufacturers’ instructions [J]. Obstet Gynecol, 2012, 120(4): 865-870.
[12]	Cooper J, Gimpelson R, Laberge P. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia [J].J Am Assoc Gynecol Laparosc,2002, 9(4): 418-428.
[13]	Campbell P, Monaghan C. NovaSure endometrial ablation: a review of 400 cases [J]. Gynecol Surg, 2012, 9: 73-76.
[14]	Baggish M S, Bhati A. Intestinal injuries associated with the NovaSure bipolar device [J]. J Gynecol Surg, 2009,25(2):135-140.
[15]	ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures[J]. Obstet Gynecol,2009, 113(5):1180-1189.
[16]	NovaSure Impedance-controlled Endometrial Ablation System: Instructions for Use and Controller’s Manual. Marlborough, MA: Hologic, Inc; 2010.
[17]	Khan Z, El-Nashar S A, Hopkins M R, et al. Efficacy and safety of global endometrial ablation after cesarean delivery: a cohort study [J]. Am J Obstet Gynecol, 2011, 205(5): 450.e1-450.e4.
[18]	Lee M H, Kadra M. Predictive factors affecting the success of a NovaSure endometrial ablation [J]. Hong Kong J Gynaecol Obstet Midwifery, 2013, E13(1): 1-7.
[19]	Alhilli M M, Hopkins M R, Famuyide A O. Endometrial cancer after endometrial ablation: systematic review of medical literature [J]. JMIG, 2011, 18(3): 393-400.
[20]	Krogh R A, Lauszus F F, Guttorm E, et al. Surgery and cancer after endometrial resection. Long-term follow-up on menstrual bleeding and hormone treatment by questionnaire and registry [J].Arch Gynecol Obstet, 2009, 280(6): 911-916.
[21]	Alhilli M M, Hopkins M R, Famuyide A O. Endometrial cancer after endometrial ablation: systematic review of medical literature [J].J Minim Invasive Gynecol,2011,18(3): 393-400.
[22]	Lo J S, Pickersgill A. Pregnancy after endometrial ablation: English literature review and case report [J].J Minim Invasive Gynecol, 2006,13(2): 88-91.
[23]	Smith S E, Bacher-Lind L. Pregnancy outcomes following a NovaSure endometrial ablation procedure [J].J Minim Invasive Gynecol,2012,19(6):S21.